INIS
administration
47%
alkaloids
13%
analgesics
16%
assessments
26%
brain
48%
comparative evaluations
38%
concentration
32%
control
20%
data
18%
dissolution
29%
doses
98%
drugs
75%
humans
36%
intake
14%
interactions
15%
legal aspects
16%
levels
34%
lysergic acid
18%
pain
19%
patients
17%
performance
17%
populations
30%
psychological behavior
23%
range
13%
reduction
26%
reviews
22%
safety
25%
surveys
23%
symptoms
28%
utilities
14%
Keyphrases
4-fluoroamphetamine
19%
5-methoxy-N,N-dimethyltryptamine
19%
Altered States of Consciousness
20%
Ayahuasca
50%
Cannabis
50%
Cannabis Use
13%
Cannabis Users
19%
Ceremony
17%
Creative Thinking
13%
Ego Dissolution
18%
Empathy
14%
Functional Connectome
12%
Glutamate
12%
Healthy Volunteers
28%
JWH-018
14%
Life Satisfaction
14%
Lysergic Acid Diethylamide
16%
Mental Health
12%
Microdosing
14%
Neuroadaptation
13%
Neurocognition
15%
Placebo
16%
Placebo-controlled
19%
Placebo-controlled Study
16%
Psilocybin
53%
Psychedelics
100%
Subjective Experience
21%
Synthetic Cannabinoids
16%
Well-being
18%
Δ9-tetrahydrocannabinol (Δ9-THC)
13%